Study, Feb./17: The direct actions of cannabidiol, etc. at GABAA Receptors

The full title of this Australian study is "The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors".

"Cannabidiol (CBD) is a major non-intoxicating component of cannabis and possesses anti-epileptic, anxiolytic and anti-hyperalgesic properties. The mechanism of action of CBD in producing such effects remains unclear. Despite evidence that some endogenous and synthetic cannabinoids interact with GABAA receptors, no-one has yet investigated the effects of CBD."

https://www.ncbi.nlm.nih.gov/pubmed/28249817